Streptococcus dysgalactiae subsp.-equisimilis as an emerging secondary pathogen in leprosy foot ulcers
Abstract
Background and Objectives: Leprosy foot ulcers (LFU) tend to become chronic due to secondary bacterial infections, leading to subsequent disfigurement and disability. Treatment modality for infected plantar ulcers thus so far is majorly based on conventional approach of empirical antibacterial therapy. However, this approach tends to overlook unconventional pathogens which are likely to be present in the LFU.
Materials and Methods: Twenty-six leprosy patients (17 males and 9 females) who had completed multidrug therapy (MDT) and those are suffering from foot ulcer were included. Using sterile cotton swabs, two wound swabs were collected, of these; one for bacterial culture and another for NGS (Next Generation Sequencing).
Results: Out of 26 samples tested on conventional bacterial culture, Streptococcus spp. (50%) was predominant organism. On NGS, 09/26 (34.61%) showed Streptococcus-dysgalactiae-subsp.-equisimilis-GGS 12 as the most abundant single organism, along with some unknown and unclassified organisms; 03/26 (11.5%) were Arcanobacterium-haemolyticum-DSM-20595 alone and 02/26 (7.69%) were Streptococcus-pyogenes alone. A combination of Arcanobacterium-haemolyticum-DSM-20595 and Streptococcus-dysgalactiae-subsp.-equisimilis-GGS 124 was found in nine (34.61%) specimens.
Conclusion: Polymicrobial infection with conventional and unconventional pathogenic bacteria is another notable finding suggesting appropriate interventions. The study findings also reiterate the need for understanding the polymicrobial infections and their role in the clinical progression of the LFU.
2. Boulton AJ. Diabetic foot--what can we learn from leprosy? Legacy of Dr Paul W. brand. Diabetes Metab Res Rev 2012; 28 Suppl 1: 3-7.
3. World Health Organization (2021). Towards zero leprosy: global Leprosy (Hansen’s disease) Strategy 2021–2030. World Health Organization.
4. Tiwari A, Suryawanshi P, Raikwar A, Arif M, Richardus JH. Household expenditure on leprosy outpatient services in the Indian health system: A comparative study. PLoS Negl Trop Dis 2018; 12(1): e0006181.
5. Bessa LJ, Fazii P, Di Giulio M, Cellini L. Bacterial isolates from infected wounds and their antibiotic susceptibility pattern: some remarks about wound infection. Int Wound J 2015; 12: 47-52.
6. Ebineshan KU, Pallapati MS, Srikantam A. Occurrence of bacterial biofilm in leprosy plantar ulcers. Lepr Rev 2020; 91: 130-138.
7. Saha R, Sarkar S, Majumder M, Banerjee G. Bacteriological profile of aerobic and anaerobic isolates of trophic ulcer in leprosy: A study from eastern India. Indian J Dermatol 2019; 64: 372-376.
8. Ramos JM, Pérez-Tanoira R, García-García C, Prieto-Pérez L, Bellón MC, Mateos F, et al. Leprosy ulcers in a rural hospital of Ethiopia: pattern of aerobic bacterial isolates and drug sensitivities. Ann Clin Microbiol Antimicrob 2014; 13: 47.
9. Malini A, Deepa EK, Manohar PV, Borappa K, Prasad SR. Soft tissue infections with Arcanobacterium haemolyticum: report of three cases. Indian J Med Microbiol 2008; 26: 192-195.
10. Wensel CR, Pluznick JL, Salzberg SL, Sears CL. Next-generation sequencing: insights to advance clinical investigations of the microbiome. J Clin Invest 2022; 132(7): e154944.
11. Tille P (2015). Bailey & Scott's diagnostic microbiology-E-Book. Elsevier Health Sciences.
12. Takahashi S, Tomita J, Nishioka K, Hisada T, Nishijima M. Development of a prokaryotic universal primer for simultaneous analysis of Bacteria and Archaea using next-generation sequencing. PLoS One 2014; 9(8): e105592.
13. Dehingia M, Devi KT, Talukdar NC, Talukdar R, Reddy N, Mande SS, et al. Gut bacterial diversity of the tribes of India and comparison with the worldwide data. Sci Rep 2015; 5: 18563.
14. Antimicrobial stewardship programmes in health-care facilities in low- and middle-income countries: a WHO practical toolkit. JAC Antimicrob Resist 2019; 1: dlz072.
15. Gelatti LC, Bonamigo RR, Becker AP, Eidt LM, Ganassini L, d' Azevedo PA. Phenotypic, molecular and antimicrobial susceptibility assessment in isolates from chronic ulcers of cured leprosy patients: a case study in Southern Brazil. An Bras Dermatol 2014; 89: 404-408.
16. Yung L, Rashid M, Bräu N. Group C Streptococcus dysgalactiae subsp.equisimilis (SDSE) endocarditis with endogenous endophthalmitis and aortic root Abscess. IDCases 2019; 15: e00513.
17. Kittang BR, Langeland N, Skrede S, Mylvaganam H. Two unusual cases of severe soft tissue infection caused by Streptococcus dysgalactiae subsp. equisimilis. J Clin Microbiol 2010; 48: 1484-1487.
18. Travis J, Malone M, Hu H, Baten A, Johani K, Huygens F, et al. The microbiome of diabetic foot ulcers: a comparison of swab and tissue biopsy wound sampling techniques using 16S rRNA gene sequencing. BMC Microbiol 2020; 20: 163.
19. Bowler PG, Duerden BI, Armstrong DG. Wound microbiology and associated approaches to wound management. Clin Microbiol Rev 2001; 14: 244-269.
20. Thwe PM, Ren P, Loeffelholz M (2024). Chapter 91 - Genomic analysis of microbial infections. In Mol Med Microbiol (Third Edition). Academic Press. Pp.1907-1929. https://www.sciencedirect.com/science/article/abs/pii/B9780128186190000630?via%3Dihub
21. White C, Franco-Paredes C. Leprosy in the 21st century. Clin Microbiol Rev 2015; 28: 80-94.
22. Kale DS, Karande GS, Datkhile KD. Diabetic foot ulcer in India: Aetiological trends and bacterial diversity. Indian J Endocrinol Metab 2023; 27: 107-114.
23. Puri V, Venkateshwaran N, Khare N. Trophic ulcers-Practical management guidelines. Indian J Plast Surg 2012; 45: 340-351.
| Files | ||
| Issue | Vol 16 No 5 (2024) | |
| Section | Original Article(s) | |
| DOI | https://doi.org/10.18502/ijm.v16i5.16795 | |
| Keywords | ||
| Leprosy; Foot ulcer; 16S rRNA; Microbiome; Next generation sequencing | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
